Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium Gunter E. UmbachVerena HugBenjamin Drewinko Preclinical Studies Pages: 263 - 265
Phase II study of carminomycin in a human tumor cloning assay Marcel RozencweigCharlotte SandersJean Klastersky Preclinical Studies Pages: 267 - 270
The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension M. L. SlevinE. M. PiallT. A. Lister Pharmacologic Studies Pages: 271 - 276
A method for the simultaneous measurement of the new anthracycline derivative 4′ -deoxydoxorubicin and its metabolites by reversed phase liquid chromatography Yei-Mei PengDavid S. AlbertsThomas P. Davis Pharmacologic Studies Pages: 277 - 280
Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses S. KaplanC. SessaF. Cavalli Phase I Trials Pages: 281 - 286
Phase I study with 4′ -deoxydoxorubicin Laura FerrariAnna RossiGianni Bonadonna Phase I Trials Pages: 287 - 295
A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule Rudolf A. JossShoshanna KaplanFranco Cavalli Phase I Trials Pages: 297 - 304
A Phase I trial of spirogermanium administered on a continuous infusion schedule Paul V. WoolleyJames D. AhlgrenPhilip S. Schein Phase I Trials Pages: 305 - 309
Phase I evaluation of AT-125 single dose every three weeks Sarah TaylorRobert J. BeltBarth Hoogstraten Phase I Trials Pages: 311 - 314
Phase II study of epirubicin in advanced malignant melanoma Massimo LopezCarlo-Federico PernoAldo Barduagni Phase II Trials Pages: 315 - 317
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma Massimo LopezCarlo-Federico PernoAldo Barduagni Phase II Trials Pages: 319 - 322
Vindesine in advanced breast cancer, lymphoma and melanoma Nicholas J. DiBellaRobert BerrisArthur Sakamoto Phase II Trials Pages: 323 - 328
Phase II trial of mitoxantrone in head and neck cancer Matti S. AaproDavis S. Alberts Phase II Trials Pages: 329 - 330
Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma Frederick B. StehmanJohn A. BlessingEdgardo L. Yordan Phase II Trials Pages: 331 - 333
m-AMSA and adenocarcinoma of the endometrium Robert D. HilgersSewa S. LeghaEdward V. Hannigan Phase II Trials Pages: 335 - 338
Chemotherapy of advanced non-small cell lung cancer Bonnie J. TakasugiThomas P. Miller Review Article Pages: 339 - 347